The interface between veterinary and human antibiotic use

Annals of the New York Academy of Sciences

Volumn 1213, Issue 1, 2010, Pages 92-105

  Shryock, Thomas R ^a   Richwine, Amy ^a  

^a ELANCO ANIMAL HEALTH   (United States)

Author keywords

Animal; Antimicrobial; Food; Innovation; Resistance; Veterinary

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPENICILLIN; ANSAMYCIN DERIVATIVE; ANTIBIOTIC AGENT; AZITHROMYCIN; BACITRACIN; CARBAPENEM DERIVATIVE; CEFOTAXIME; CEFTIOFUR; CEPHALOSPORIN DERIVATIVE; CHLORTETRACYCLINE; CIPROFLOXACIN; ENROFLOXACIN; GLYCOPEPTIDE; IMMUNOMODULATING AGENT; LIPOPEPTIDE; MACROLIDE; OXAZOLIDINONE DERIVATIVE; PENICILLIN DERIVATIVE; PROBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOGRAMIN; SULFONAMIDE; TETRACYCLINE; TIGECYCLINE; TUBERCULOSTATIC AGENT; TULATHROMYCIN; UNINDEXED DRUG; VACCINE; VETERINARY DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; CAMPYLOBACTERIOSIS; DRUG STRUCTURE; DRUG USE; FOOD CONTAMINATION; FOOD SAFETY; HUMAN; NONHUMAN; SALMONELLOSIS; VETERINARY MEDICINE;

ANIMALIA;

EID: 78650374117     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05788.x     Document Type: Article

References (73)

1. The Medical Impact of the Use of Antimicrobials in Food Animals: Report and Proceedings of a WHO Meeting, Berlin, Germany, 13-17 October 1997, WHO/EMC/ZOO/97.4. (accessed June 3, 2010).
2. Shlaes, D.M., S.J. Projan & J.E. Edwards, Jr. 2004. Antibiotic discovery: state of the state. Am. Soc. Microbiol. News 70: 275-281.
3. World Agriculture: toward 2015/2030. 2002. United Nations Food and Agriculture Organization, Rome. (accessed June 3, 2010).
4. One Health Initiative. (accessed June 3, 2010).
5. Aarestrup, F.M., H.C. Wegener & P. Collignon 2008. Resistance in bacteria of the food chain: epidemiology and control strategies. Expert Rev. Anti-infect. Therap. 6: 733-750.
6. JETACAR report. (accessed June 3, 2010).
7. FAO/WHO/OIE. 2008. Joint FAO/WHO/OIE Expert Meeting on Critically Important Antimicrobials. Report of a meeting held in FAO, Rome, Italy, 26-30 November 2007. FAO, Rome, Italy, and WHO, Geneva, Switzerland. (accessed June 3, 2010).
8. Mathew, A.G., R. Sissel & S. Liamthong 2007. Antibiotic resistance in bacteria associated with food animals: a United States perspective of livestock production. Foodborne Pathogens Dis. 4: 115-133.
9. Codex Alimentarius Code of Practice to minimize and contain antimicrobial resistance. CAC/RCP 61. (accessed June 3, 2010).
10. OIE Terrestrial Animal Health Code. Antimicrobial resistance. Responsible and prudent use of antimicrobial agents in veterinary medicine. (accessed June 3, 2010).
11. World Veterinary Association/International Federation of Animal Producers/World Federation of the Animal Health Industry Prudent Use of Antibiotics: Global Basic Principles. (accessed June 3, 2010).
12. WHO Responsible Use Guidelines for Antibiotics. (accessed June 3, 2010).
13. American Veterinary Medical Association Position Statement and Principles for Judicious Therapeutic Antimicrobial Use by Veterinarians. (accessed June 3, 2010).
14. Federation of Veterinarians of Europe Antibiotic Resistance & Prudent Use of Antibiotics in Veterinary Medicine. (accessed June 3, 2010).
15. Vose D.J., J. Acar, F. Anthony, et al. 2001. Antimicrobial resistance: risk analysis methodology for the potential impact on public health of antimicrobial resistant bacteria of animal origin. Rev. - Off. Int. Epizoot 20: 811-827.
16. OIE Terrestrial Code Risk assessment for antimicrobial resistance arising from the use of antimicrobials in animals. (accessed June 3, 2010).
17. VICH GL27 Guidance on pre-approval information for registration of new veterinary medicinal products for food producing animals with respect to antimicrobial resistance (adopted as CVMP 644 in Europe). (accessed June 3, 2010).
18. APVMA Part 10 Special Data: Antibiotic Resistance. (accessed June 3, 2010).
19. US FDA CVM Guidance 152 Evaluating the safety of antimicrobial new animal drugs with regard to their microbiological effects on bacteria of human health concern. (accessed June 3, 2010).
20. US FDA CVM draft Guidance 209. The Judicious Use of Medically Important Antimicrobial Drugs in Food-Producing Animals. (accessed September 22, 2010).
21. CVM VMAC cefquinome. (accessed June 3, 2010).
22. Enrofloxacin for poultry withdrawal of approval of Bayer Corporation's New Animal Drug Application (NADA) 140-828 (Baytril) Docket No. 2000N-1571. (accessed June 3, 2010).
23. CVMP Reflection paper on the use of fluoroquinolones in food producing animals-precautions for use in the SPC regarding prudent use guidance. (accessed June 3, 2010).
24. CVMP Revised Reflection paper on the use of 3rd and 4th generation cephalosporins in food producing animals in the European Union: development of resistance and impact on human and animal health. (accessed June 3, 2010).
25. FDA Issues Order Prohibiting Extralabel Use of Cephalosporin Antimicrobial Drugs July 2, 2008. (accessed June 3, 2010).
26. FDA Revokes Order Prohibiting Extralabel Use of Cephalosporin November 25, 2008. (accessed June 3, 2010).
27. FDA CDER Advisory Committee Meeting 2003. (accessed June 3, 2010).
28. Canadian Veterinary Drug Directorate Current thinking on risk management measures to address antimicrobial resistance associated with the use of antimicrobial agents in food-producing animals. (accessed June 3, 2010).
29. Japan Food Safety Commission Antimicrobial Resistance. (accessed June 3, 2010).
30. 1st Joint FAO/OIE/WHO Expert workshop on non-human antimicrobial usage and antimicrobial resistance: scientific assessment, Geneva, December 1-5, 2003. (accessed June 3, 2010).
31. 2nd Joint FAO/OIE/WHO Expert workshop on non-human antimicrobial usage and antimicrobial resistance: management options, Oslo, November 15-18, 2004. (accessed June 3, 2010).
32. Critically Important Antimicrobials for Human Medicine: Categorization for the Development of Risk Management Strategies to Contain Antimicrobial Resistance due to Non-Human Antimicrobial Use Report of the Second WHO Expert Meeting, Copenhagen, 29-31 May 2007. (accessed June 3, 2010).
33. Collignon, P., J.H. Powers, T.M. Chiller, et al. 2009. World Health Organization ranking of antimicrobials according to their importance in human medicine: a critical step for developing risk management strategies for the use of antimicrobials in food production animals. Clin. Infect. Dis. 49: 132-141.
34. WHO AGISAR meeting. 2009. (accessed June 3, 2010).
35. COUNCIL REGULATION (EC) No 2821/98 of 17 December 1998 amending, as regards withdrawal of the authorisation of certain antibiotics, Directive 70/524/EEC concerning additives in feeding stuffs. (accessed June 3, 2010).
36. H.R. 1549: Preservation of Antibiotics for Medical Treatment Act of 2009. (accessed June 3, 2010).
37. McDonalds Antibiotic Policy. (accessed June 3, 2010).
38. Keep Antibiotics Working Coalition. (accessed June 3, 2010).
39. IMS Global Pharmaceutical Sales 2001-2008. (accessed June 3, 2010).
40. Gootz, T.D. 2010. The global problem of antibiotic resistance. Crit. Rev. Immunol. 30: 79-93.
41. Federal Register/Vol. 74, No. 205 / Monday, October 26, 2009/ Notices 55047.
42. Animal Health Institute 2007 active antibacterial ingredients. (accessed June 3, 2010).
43. Animal Health Institute Industry Overview. (accessed June 3, 2010).
44. Biopharma spend. (accessed June 3, 2010) (URL works only if pasted into Google).
45. Shryock, T.R. 2004. The future of anti-infective products in animal health. Nat. Rev. Microbiol. 2: 425-430.
46. Thomas, V., A. de Jong, P. Butty, et al. 2009. Antibiotic susceptibility of respiratory tract pathogens isolated from diseased cattle and swine in Europe. Proceedings from a meeting of the Europ. Assoc. Vet. Pharmacol. Toxicol. Leipzig, Germany P308.
47. IFAH Europe European Technology Platform for Global Animal Health. (accessed June 3, 2010) (URL works only if pasted into Google).
48. United Nations Millenium Goals. (accessed June 3, 2010).
49. Falconer, S.B. & E.D. Brown 2009. New screens and targets in antibacterial drug discovery. Curr. Opin. Microbiol. 12: 497-504.
50. Mathers, J.J., S.R. Clark, D. Hausman, et al. 2004. Inhibition of resistance plasmid transfer in Escherichia coli by ionophores, chlortetracycline, bacitracin, and ionophore/antimicrobial combinations. Avian Dis. 48: 317-323.
51. Pfaller, M.A. 2006. Flavophospholipol use in animals: positive implications for antimicrobial resistance based on its microbiologic properties. Diagn. Microbiol. Infect. Dis. 56: 115-121.
52. DeNap, J.C.B, J.R. Thomas, D.J. Musk, et al. 2004.Combating drug-resistant bacteria: small molecule mimics of plasmid incompatibility as antiplasmid compounds. J. Am. Chem. Soc. 126: 15402-15404.
53. Williams, J.J. & P.J. Hergenrother 2008. Exposing plasmids as the Achilles' heel of drug-resistant bacteria. Curr. Opin. Chem. Biol. 12: 389-399.
54. Cushnie, T.P.T. & A.J. Lamb 2005. Antimicrobial activity of flavonoids. Int. J. Antimicrob. Agents. 26: 343-356.
55. Butler, M.S. & A.D. Buss 2006. Natural products-the future scaffolds for novel antibiotics? Biochem. Pharmacol. 71: 919-929.
56. Boyen, F., V. Eeckhaut, F. Van Immerseel, et al. 2009. Quorum sensing in veterinary pathogens: mechanisms, clinical importance and future perspectives. Vet. Microbiol. 135: 187-195.
57. Escaich, S. 2008. Antivirulence as a new antibacterial approach for chemotherapy. Curr. Opin. Chem. Biol. 12: 400-408.
58. Brogden, K.A. 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3: 238-250.
59. Brogden, K.A., M. Ackermann, P.B. McCray, et al. 2003. Antimicrobial peptides in animals and their role in host defences. Int. J. Antimicrob. Agents 22: 465-478.
60. Gillor, O. A., Etzion & M.A. Riley 2008. The dual role of bacteriocins as anti- and probiotics. Appl. Microbiol. Biotechnol. 81: 591-606.
61. Scott, M.G., E. Dullaghan, N. Mookherjee, et al. 2007. An anti-infective peptide that selectively modulates the innate immune response. Nat. Biotechnol. 25: 465-472.
62. Wang, W.M., R. She, Qu. Sun, et al. 2009. Effects of swine gut antimicrobial peptides on the intestinal mucosal immunity in specific-pathogen-free chickens. Poultry Sci. 88: 967-974.
63. Lowenthal, J.W., B. Lambrecht, T.P. Van Den Berg, et al. 2000. Avian cytokines-the natural approach to therapeutics. Dev. Comp. Immunol. 24: 355-365.
64. Molineux, I.J. 2006. Fifty-three years since Hershey and Chase; much ado about pressure but which pressure is it? Virology 344: 221-229.
65. Barrow, P.A. 2001. The use of bacteriophages for treatment and prevention of bacterial disease in animals and animal models of human infection. J. Chem. Technol. Biotechnol. 76: 677-682.
66. Joerger, R.D. 2003. Alternatives to antibiotics: bacteriocins, antimicrobial peptides and bacteriophages. Poult. Sci. 82: 640-647.
67. Wall, S.K., J. Zhang, M.H. Rostagno, et al. 2010. Phage therapy to reduce preprocessing Salmonella infections in market-weight swine. Appl. Environ. Microbiol. 76: 48-53.
68. Sulakvelidze, A. & P. Barrow 2005. Phage therapy in animals and agribusiness. In Bacteriophages Biology and Applications. E. Kutter & A. Sulakvelidze, Eds.: 335-380. CRC Press. New York
69. Callaway, T.R, T.S. Edrington, A.D. Brabban, et al. 2008. Bacteriophage isolated from feedlot cattle can reduce Escherichia coli O157:H7 populations in ruminant gastrointestinal tracts. Foodborne Pathogens Dis. 5: 183-191.
70. Wagenaar, J.A., M.A.P. Van Bergen, M. A. Mueller, et al. 2005. Phage therapy reduces Campylobacter jejuni colonization in broilers. Vet. Microbiol. 109: 275-283.
71. Miller, R.W., J. Skinner, A. Sulakvelidze, et al. 2010. Bacteriophage therapy for control of necrotic enteritis of broiler chickens experimentally infected with Clostridium perfringens. Avian Dis. 54: 33-40.
72. Heldens, J.G.M., J.R. Patel, N. Chanter, et al. 2008. Veterinary vaccine development from an industrial perspective. Vet. J. 178: 7-20.
73. Walker, R. & M. Buckley 2006. Probiotic Microbes: The Scientific Basis. Am. Soc. Microbiol. Washington, DC (accessed June 3, 2010).